These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 27479215

  • 1. Myocardial Expression Analysis of Osteopontin and Its Splice Variants in Patients Affected by End-Stage Idiopathic or Ischemic Dilated Cardiomyopathy.
    Cabiati M, Svezia B, Matteucci M, Botta L, Pucci A, Rinaldi M, Caselli C, Lionetti V, Del Ry S.
    PLoS One; 2016; 11(8):e0160110. PubMed ID: 27479215
    [Abstract] [Full Text] [Related]

  • 2. Osteopontin: a potential biomarker for heart failure and reverse remodeling after left ventricular assist device support.
    Schipper ME, Scheenstra MR, van Kuik J, van Wichen DF, van der Weide P, Dullens HF, Lahpor J, de Jonge N, De Weger RA.
    J Heart Lung Transplant; 2011 Jul; 30(7):805-10. PubMed ID: 21531579
    [Abstract] [Full Text] [Related]

  • 3. Regional heterogeneity of decreased myocardial norepinephrine and increased lipid peroxidation levels in patients with end-stage failing heart secondary to dilated or ischemic cardiomyopathy.
    Rochette L, Tatou E, Vergely C, Maupoil V, Bouchot O, Mossiat C, Jazayeri S, Benkhadra S, Brenot R, Girard C, David M.
    J Heart Lung Transplant; 2008 Jul; 27(7):767-74. PubMed ID: 18582807
    [Abstract] [Full Text] [Related]

  • 4. Selective downregulation of VEGF-A(165), VEGF-R(1), and decreased capillary density in patients with dilative but not ischemic cardiomyopathy.
    Abraham D, Hofbauer R, Schäfer R, Blumer R, Paulus P, Miksovsky A, Traxler H, Kocher A, Aharinejad S.
    Circ Res; 2000 Oct 13; 87(8):644-7. PubMed ID: 11029398
    [Abstract] [Full Text] [Related]

  • 5. Osteopontin: a fibrosis-related marker molecule in cardiac remodeling of enterovirus myocarditis in the susceptible host.
    Szalay G, Sauter M, Haberland M, Zuegel U, Steinmeyer A, Kandolf R, Klingel K.
    Circ Res; 2009 Apr 10; 104(7):851-9. PubMed ID: 19246678
    [Abstract] [Full Text] [Related]

  • 6. Left-ventricular expression of interleukin-6 messenger-RNA higher in idiopathic dilated than in ischemic cardiomyopathy.
    Plenz G, Song ZF, Reichenberg S, Tjan TD, Robenek H, Deng MC.
    Thorac Cardiovasc Surg; 1998 Aug 10; 46(4):213-6. PubMed ID: 9776495
    [Abstract] [Full Text] [Related]

  • 7. Effects of surgical ventricular reconstruction and mitral complex reconstruction on cardiac oxidative metabolism and efficiency in nonischemic and ischemic dilated cardiomyopathy.
    Sugiki T, Naya M, Manabe O, Wakasa S, Kubota S, Chiba S, Iwano H, Yamada S, Yoshinaga K, Tamaki N, Tsutsui H, Matsui Y.
    JACC Cardiovasc Imaging; 2011 Jul 10; 4(7):762-70. PubMed ID: 21757167
    [Abstract] [Full Text] [Related]

  • 8. Selective upregulation of cardiac endothelin system in patients with ischemic but not idiopathic dilated cardiomyopathy: endothelin-1 system in the human failing heart.
    Serneri GG, Cecioni I, Vanni S, Paniccia R, Bandinelli B, Vetere A, Janming X, Bertolozzi I, Boddi M, Lisi GF, Sani G, Modesti PA.
    Circ Res; 2000 Mar 03; 86(4):377-85. PubMed ID: 10700441
    [Abstract] [Full Text] [Related]

  • 9. Osteopontin in hepatocellular carcinoma: A possible biomarker for diagnosis and follow-up.
    Cabiati M, Gaggini M, Cesare MM, Caselli C, De Simone P, Filipponi F, Basta G, Gastaldelli A, Del Ry S.
    Cytokine; 2017 Nov 03; 99():59-65. PubMed ID: 28711012
    [Abstract] [Full Text] [Related]

  • 10. Increased Ca2+ sensitivity of myofibrillar tension in ischaemic vs dilated cardiomyopathy.
    Lee S, Lu R, Müller-Ehmsen J, Schwinger RH, Brixius K.
    Clin Exp Pharmacol Physiol; 2010 Dec 03; 37(12):1134-8. PubMed ID: 20804510
    [Abstract] [Full Text] [Related]

  • 11. Nicotinamide phosphoribosyltransferase/pre-B-cell colony enhancing factor/visfatin plasma levels and clinical outcome in patients with dilated cardiomyopathy.
    Bobbert P, Kühl U, Poller W, Rauch U, Schultheiss HP, Skurk C.
    J Card Fail; 2015 Apr 03; 21(4):330-8. PubMed ID: 25498756
    [Abstract] [Full Text] [Related]

  • 12. Regional mapping of myocardial hibernation phenotype in idiopathic end-stage dilated cardiomyopathy.
    Lionetti V, Matteucci M, Ribezzo M, Di Silvestre D, Brambilla F, Agostini S, Mauri P, Padeletti L, Pingitore A, Delsedime L, Rinaldi M, Recchia FA, Pucci A.
    J Cell Mol Med; 2014 Mar 03; 18(3):396-414. PubMed ID: 24444256
    [Abstract] [Full Text] [Related]

  • 13. Cardiac unloading by LVAD support differentially influences components of the cGMP-PKG signaling pathway in ischemic and dilated cardiomyopathy.
    Persoon S, Paulus M, Hirt S, Jungbauer C, Dietl A, Luchner A, Schmid C, Maier LS, Birner C.
    Heart Vessels; 2018 Aug 03; 33(8):948-957. PubMed ID: 29546540
    [Abstract] [Full Text] [Related]

  • 14. Molecular and cellular correlates of cardiac function in end-stage DCM: a study using speckle tracking echocardiography.
    Cordero-Reyes AM, Youker K, Estep JD, Torre-Amione G, Nagueh SF.
    JACC Cardiovasc Imaging; 2014 May 03; 7(5):441-52. PubMed ID: 24726255
    [Abstract] [Full Text] [Related]

  • 15. Plasma osteopontin levels, but not its myocardial expression, reflect heart failure severity in recently diagnosed dilated cardiomyopathy.
    Podzimkova J, Palecek T, Kuchynka P, Marek J, Danek BA, Jachymova M, Safarikova M, Kalousova M, Zima T, Linhart A.
    Herz; 2020 Dec 03; 45(Suppl 1):105-110. PubMed ID: 31289910
    [Abstract] [Full Text] [Related]

  • 16. Regulation of adverse remodelling by osteopontin in a genetic heart failure model.
    Psarras S, Mavroidis M, Sanoudou D, Davos CH, Xanthou G, Varela AE, Panoutsakopoulou V, Capetanaki Y.
    Eur Heart J; 2012 Aug 03; 33(15):1954-63. PubMed ID: 21525025
    [Abstract] [Full Text] [Related]

  • 17. Functional networks of nucleocytoplasmic transport-related genes differentiate ischemic and dilated cardiomyopathies. A new therapeutic opportunity.
    Molina-Navarro MM, Triviño JC, Martínez-Dolz L, Lago F, González-Juanatey JR, Portolés M, Rivera M.
    PLoS One; 2014 Aug 03; 9(8):e104709. PubMed ID: 25137373
    [Abstract] [Full Text] [Related]

  • 18. Impaired VE-cadherin/beta-catenin expression mediates endothelial cell degeneration in dilated cardiomyopathy.
    Schäfer R, Abraham D, Paulus P, Blumer R, Grimm M, Wojta J, Aharinejad S.
    Circulation; 2003 Sep 30; 108(13):1585-91. PubMed ID: 12963640
    [Abstract] [Full Text] [Related]

  • 19. RNA sequencing analysis and atrial natriuretic peptide production in patients with dilated and ischemic cardiomyopathy.
    Tarazón E, Roselló-Lletí E, Rivera M, Ortega A, Molina-Navarro MM, Triviño JC, Lago F, González-Juanatey JR, Orosa P, Montero JA, Salvador A, Portolés M.
    PLoS One; 2014 Sep 30; 9(3):e90157. PubMed ID: 24599027
    [Abstract] [Full Text] [Related]

  • 20. Expression of ten RGS proteins in human myocardium: functional characterization of an upregulation of RGS4 in heart failure.
    Mittmann C, Chung CH, Höppner G, Michalek C, Nose M, Schüler C, Schuh A, Eschenhagen T, Weil J, Pieske B, Hirt S, Wieland T.
    Cardiovasc Res; 2002 Sep 30; 55(4):778-86. PubMed ID: 12176127
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.